![Sam Jactel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Bruno Jactel | M | 62 |
Hypercell Technologies, Inc.
![]() Hypercell Technologies, Inc. Packaged SoftwareTechnology Services Hypercell Technologies, Inc. has developed a proprietary point-of-care diagnostic technology platform that allows for the early identification and management of biological contaminants in the food chain, from production to transformation. The private company is based in Brookhaven, GA and was founded by Bruno Jactel, who has been the CEO since incorporation. Despite advances in vaccines and testing tools, production animal diseases still cost $10 billion in lost productivity and threaten the human population when animal diseases jump to the human species. Food-borne diseases impact 48 million Americans every year and cost the economy more than $55 billion/year. Hypercell's solution is as accurate as the gold standard PCR, 10x faster, and without expensive lab equipment. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 1 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Sam Jactel
- Persoonlijk netwerk